ATE451393T1 - Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln - Google Patents

Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln

Info

Publication number
ATE451393T1
ATE451393T1 AT04806335T AT04806335T ATE451393T1 AT E451393 T1 ATE451393 T1 AT E451393T1 AT 04806335 T AT04806335 T AT 04806335T AT 04806335 T AT04806335 T AT 04806335T AT E451393 T1 ATE451393 T1 AT E451393T1
Authority
AT
Austria
Prior art keywords
antibody fragments
human anti
new
idiotypic antibody
fragments similar
Prior art date
Application number
AT04806335T
Other languages
English (en)
Inventor
Philippe Gauthier
Andre Pelegrin
Mickael Coelho
Isabelle Teulon
Original Assignee
Inst Nat Sante Rech Med
Ct Regional De Lutte Contre Le
Univ Montpellier I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Ct Regional De Lutte Contre Le, Univ Montpellier I filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE451393T1 publication Critical patent/ATE451393T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04806335T 2003-12-17 2004-12-14 Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln ATE451393T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03293196A EP1544215A1 (de) 2003-12-17 2003-12-17 Humane antiidiotypische Antikörperfragmente die HER-2/neu nachahmen
PCT/IB2004/004096 WO2005061546A1 (en) 2003-12-17 2004-12-14 Human anti-idiotypic antibody fragments that mimic her-2/neu

Publications (1)

Publication Number Publication Date
ATE451393T1 true ATE451393T1 (de) 2009-12-15

Family

ID=34486483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04806335T ATE451393T1 (de) 2003-12-17 2004-12-14 Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln

Country Status (8)

Country Link
US (2) US7892542B2 (de)
EP (2) EP1544215A1 (de)
JP (1) JP4709161B2 (de)
AT (1) ATE451393T1 (de)
CA (1) CA2549937A1 (de)
DE (1) DE602004024574D1 (de)
ES (1) ES2335350T3 (de)
WO (1) WO2005061546A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003256299A1 (en) 2002-07-01 2004-01-19 Human Genome Sciences, Inc. Antibodies that specifically bind to reg iv
FR2879605B1 (fr) * 2004-12-16 2008-10-17 Centre Nat Rech Scient Cnrse Production de formats d'anticorps et applications immunologiques de ces formats
CA2822302A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Methods of impairing osteoclast differentiation
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
US8501417B2 (en) 2007-06-26 2013-08-06 Vanderbilt University Immunological compositions as cancer biomarkers and/or therapeutics
WO2010130677A1 (en) * 2009-05-13 2010-11-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vhh antibody fragments that mimic her-2/neu
ES2723885T3 (es) 2012-07-19 2019-09-03 Daiichi Sankyo Co Ltd Anticuerpos anti-Siglec-15
CN108699161B (zh) * 2016-03-04 2022-06-03 莫佛塞斯公司 多发性骨髓瘤中m-蛋白应答的临床评估
EP4021501A4 (de) * 2019-09-10 2023-09-13 The Research Foundation for The State University of New York Zusammensetzungen und verfahren zum verbessern der tumorpenetration von tumorspezifischen antikörpern
WO2024243578A1 (en) * 2023-05-25 2024-11-28 Dispatch Biotherapeutics, Inc. Synthetic cancer antigens as targets for treating cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637677A (en) * 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
US5560911A (en) * 1993-10-12 1996-10-01 Oklahoma Medical Research Foundation Method of inhibiting acute complement mediated cytotoxicity with anti-idiotypic antibodies

Also Published As

Publication number Publication date
WO2005061546A1 (en) 2005-07-07
ES2335350T3 (es) 2010-03-25
JP4709161B2 (ja) 2011-06-22
US20110110929A1 (en) 2011-05-12
EP1694707B1 (de) 2009-12-09
EP1694707A1 (de) 2006-08-30
JP2008504221A (ja) 2008-02-14
US20070298033A1 (en) 2007-12-27
CA2549937A1 (en) 2005-07-07
US7892542B2 (en) 2011-02-22
EP1544215A1 (de) 2005-06-22
DE602004024574D1 (de) 2010-01-21

Similar Documents

Publication Publication Date Title
CY1123535T1 (el) Υποκαταστατο θεραπευτικο τελικο σημειο για βασιζομενη σε anti-ctla-4 ανοσοθεραπεια ασθενειας
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
SA519402358B1 (ar) Ccr7 مترافقات عقار جسم مضاد لـ
ATE444308T1 (de) Fusionsproteine humanisierter g250-spezifischer antikörper sowie verwendungen davon
CY1119512T1 (el) Αντισωματα του υποδοχεα 1 της ιντερφερονης αλφα και οι χρησεις αυτων
CY1117090T1 (el) Χιμαιρικες πρωτεϊνες παραγοντα πηξης για την αγωγη αιμοστατικων ασθενειων
CY1114658T1 (el) Πρωτεϊνες δεσμευσης αντιγονου του αυξητικου παραγοντα τυπου επιδερμικου αυξητικου παραγοντα προσδεσης στην ηπαρινη
PL2097453T3 (pl) Przeciwciała monoklonalne przeciw ludzkiemu receptorowi hormonu anty-Mullerowskiego typu II (AMHR-II)
TW200510459A (en) RG1 antibodies and uses thereof
WO2017004026A8 (en) Anti-cd123 antibodies and conjugates and derivatives thereof
WO2005062977A3 (en) Prostate cancer specific internalizing human antibodies
ATE516842T1 (de) Intravasculärer führungsdraht
EP1885399A4 (de) Humanisierte antikörper gegen cd40 und verfahren zu ihrer anwendung
MX2009009926A (es) Anticuerpo tumor-especifico humano monoclonal.
SI1557462T1 (sl) Celice monocitnega izvora, ki inducirajo sprejemljivost transplantata, kot tudi njihova priprava in uporaba
WO2006084078A3 (en) Jam-3 and antibodies that bind thereto
SG146644A1 (en) Kid3 and kid3 antibodies that bind thereto
DK1641828T3 (da) Anti-HGF-R-antistoffer og deres anvendelse
MX2018008926A (es) Composiciones de anticuerpo contra ror1 y métodos relacionados.
WO2005055936A3 (en) Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
ITTO20020340A1 (it) Localizzazione del recettore her2 mediante anticorpo umanizzato biotinilato.
WO2004043239A3 (en) Antigen pipa and antibodies that bind thereto
DE602004024574D1 (de) Humane anti-idiotypische antikörperfragmente, die her-2/neu ähneln
WO2006083852A3 (en) Luca2 and antibodies that bind thereto
ATE427967T1 (de) Spezifische antikírperfragmente fur das humane carcinoembryonic antigen (cea)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties